I call this meeting to order.
Welcome to meeting 101 of the House of Commons Standing Committee on Health. Today's meeting is taking place in a hybrid format pursuant to the Standing Orders.
I have a few comments for the benefit of members and those participating online.
You have interpretation available to you on Zoom. You have the choice at the bottom of your screen of floor, English or French. Those of you in the room may already know this: You can use the earpiece and select the desired channel. For those online, please bear in mind that screenshots or taking photos of your screen is not permitted.
In accordance with our routine motion, I'm informing the committee that all remote participants have completed the required connection tests in advance of the meeting.
Pursuant to Standing Order 108(2) and a motion adopted on May 16, 2022, the committee is resuming its study of women's health.
I'd like to welcome our panel of witnesses and thank them for their patience while they awaited democracy to run its course so that we could be here.
Appearing as individuals, we have Dr. Gillian Hanley, associate professor, department of obstetrics and gynaecology at the University of British Columbia. Dr. Hanley is appearing by video conference, as is Dr. Jessica McAlpine, professor and division head, division of gynecologic oncology at UBC.
Representing Ovarian Cancer Canada, we have Tania Vrionis, chief executive officer, and Valérie Dinh, regional director for Quebec.
Representing the Society of Gynecologic Oncology of Canada, we have Dr. Shannon Salvador, president-elect.
Thank you all for taking the time to appear today and for being generous with your time in awaiting our arrival.
Each of you will have five minutes for an opening statement, and we're going to begin with you, Dr. Hanley. You have the floor.
I don't mean this Dr. Hanley—